Cryptotanshinone and dihydrotanshinone i exhibit strong inhibition towards human liver microsome (HLM)-catalyzed propofol glucuronidation

Fitoterapia

Volumn 85, Issue 1, 2013, Pages 109-113

  Cong, Ming ^a   Hu, Cui Min ^c   Cao, Yun Feng ^a   Fang, Zhong Ze ^a,c   Tang, Shu Hong ^b   Wang, Jia Rui ^b   Luo, Jun Sheng ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b Fifth Hospital of Dalian   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Danshen; Herb drug interaction; UDP glucuronosyltransferases (UGTs)

Indexed keywords

ALAMETHICIN; CRYPTOTANSHINONE; DIHYDROTANSHINONE 1; PROPOFOL; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG GLUCURONIDATION; HERB DRUG INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIVER MICROSOME; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; SALVIA MILTIORRHIZA;

ANESTHETICS, INTRAVENOUS; GLUCURONOSYLTRANSFERASE; HERB-DRUG INTERACTIONS; HUMANS; MICROSOMES, LIVER; PHENANTHRENES; PLANTS, MEDICINAL; PROPOFOL; SALVIA MILTIORRHIZA;

EID: 84874745944     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.01.002     Document Type: Article

References (30)

1. P.E. Marik Propofol: an immunomodulating agent Pharmacotherapy 25 2005 S28 S33
2. R. Hermann, and J. Vettermann Change of ectopic supraventricular tachycardia to sinus rhythm during administration of propofol Anesth Analg 75 1992 1030 1032
3. S. Kannan, and N. Sherwood Termination of supraventricular tachycardia by propofol Br J Anaesth 88 2002 874 875
4. O. Miro, G. de la Red, and J. Fontanals Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration Anesthesiology 92 2000 910
5. J.E. Burjorjee, and B. Milne Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol Can J Anaesth 49 2002 973 977
6. R.H. Dong, Z.Z. Fang, L.L. Zhu, G.B. Ge, L. Yang, and Z.Y. Liu Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol Xenobiotica 42 10 2012 1009 1016
7. C.P. Strassburg, M.P. Manns, and R.H. Tukey Expression of the UDP-glucuronosyltransferase 1A locus in human colon J Biol Chem 273 1998 8719 8726
8. M.H. Court, S.X. Duan, L.L. von Moltke, D.J. Greenblatt, C.J. Patten, and J.O. Miners Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms J Pharmacol Exp Ther 299 2001 998 1006
9. M.H. Court Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases Methods Enzymol 400 2005 104 116
10. W.S. AI-Jahdari, K. Yamamoto, H. Hiraoka, K. Nakamura, F. Goto, and R. Horiuchi Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver Eur J Clin Pharmacol 62 2006 527 533
11. C.D. King, G.R. Rios, M.D. Green, and T.R. Tephly UDP- glucuronosyltransferases Curr Drug Metab 1 2000 143 161
12. J.O. Miners, K. Bowalgaha, D.J. Elliot, P. Baranczewski, and K.M. Knights Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation Drug Metab Dispos 39 4 2011 644 652
13. R.W. Jiang, K.M. Lau, P.M. Hon, T.C.W. Mak, K.S. Woo, and K.P. Fung Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza Curr Med Chem 12 2 2005 237 246
14. X. Wang, S.L. Morris-Natschke, and K.H. Lee New developments in the chemistry and biology of the bioactive constituents of Tanshen Med Res Rev 27 2007 133 148
15. K. Chan, A.C. Lo, J.H. Yeung, and K.S. Woo The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats J Pharm Pharmacol 47 1995 402 406
16. Q. Wang, H. Hao, X. Zhu, G. Yu, L. Lai, and Y. Liu Regioselective glucuronidation of tanshinone IIa after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential Drug Metab Dispos 38 7 2010 1132 1140
17. S.C. Liang, G.B. Ge, H.X. Liu, H.T. Shang, H. Wei, and Z.Z. Fang Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI-MS J Pharm Biomed Anal 54 2011 236 241
18. Z.Z. Fang, Y.Y. Zhang, G.B. Ge, H. Huo, S.C. Liang, and L. Yang Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction Br J Clin Pharmacol 69 2 2010 193 199
19. Z.Z. Fang, Y.Y. Zhang, G.B. Ge, S.C. Liang, D.X. Sun, and L.L. Zhu Identification of cytochrome P450 (CYP) isoforms involved in metabolism of corynoline and assessment of its herb-drug interaction Phytother Res 25 2011 256 263
20. D.X. Sun, Z.Z. Fang, Y.Y. Zhang, Y.F. Cao, L. Yang, and J. Yin Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes Phytother Res 24 2010 1213 1216
21. P. Goldman Herbal medicines today and the roots of modern pharmacology Ann Intern Med 135 2001 594 600
22. Z.Z. Fang, Y.Y. Zhang, X.L. Wang, Y.F. Cao, H. Huo, and L. Yang Bioactivation of herbal constituents: simple alerts in the complex system Expert Opin Drug Metab Toxicol 7 8 2011 989 1007
23. B. Guo, X.R. Fan, Z.Z. Fang, Y.F. Cao, C.M. Hu, and Y.Y. Zhang Deglycosylation of liquiritin strongly enhances its inhibitory potential towards UDP-glucuronosyltransferase (UGT) isoforms Phytother Res 2012 10.1002/ptr.4855
24. Y.P. Huang, Y.F. Cao, Z.Z. Fang, Y.Y. Zhang, C.M. Hu, and X.Y. Sun Glycyrrhetinic acid exhibits strong inhibitory effects towards UDP-glucuronosyltransferase (UGT) 1A3 and 2B7 Phytother Res 2012 10.1002/ptr.4875
25. C. Liu, Y.F. Cao, Z.Z. Fang, Y.Y. Zhang, C.M. Hu, and X.Y. Sun Strong inhibition of deoxyschizandrin and schisantherin A towards UDP- glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb-drug interaction Fitoterapia 2012 10.1016/j.fitote.2012.08.004
26. Y.J. He, Z.Z. Fang, G.B. Ge, P. Jiang, H.Z. Jin, and W.D. Zhang The inhibitory effect of 20(S)-protopanaxatriol (Ppt) towards UGT1A1 and UGT2B7 indicating a risk for UGT inhibition-based herb-drug interaction Phytother Res 2012 10.1002/ptr.4755
27. H. Takahashi, Y. Maruo, A. Mori, M. Iwai, H. Sato, and Y. Takeuchi Effect of D256N and Y483D on propofol glucuronidation by human uridine 5′-diphosphate glucuronosyltransferase (UGT1A9) Basic Clin Pharmacol Toxicol 103 2 2008 131 136
28. Y.F. Ueng, Y.H. Kuo, S.Y. Wang, Y.L. Lin, and C.F. Chen Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice Life Sci 74 7 2004 885 896
29. L. Lai, H. Hao, Q. Wang, C. Zheng, F. Zhou, and Y. Liu Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats Drug Metab Dispos 37 2009 2399 2407
30. A. Rowland, K.M. Knights, P.I. Mackenzie, and J.O. Miners The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities Drug Metab Dispos 36 6 2008 1056 1062